Martin Cornillet - Publications

Circulating multi-omic signature of disease severity and cholangiocarcinoma in primary sclerosing cholangitis.

Journal: Hepatology communications

Published: January 16, 2026

Corrigendum to "External validation of plasma CSF1 as a preoperative prognostic marker in patients with resectable intrahepatic cholangiocarcinoma" [Europ J Surg Oncol 51 (2025) 110123].

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: November 18, 2025

Molecular and cellular consequences of tumour-autonomous IL-6 signalling in intrahepatic cholangiocarcinoma.

Journal: Gut

Published: November 14, 2025

Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling.

Journal: Nature metabolism

Published: October 17, 2025

Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulations.

Journal: JHEP reports : innovation in hepatology

Published: September 17, 2025

Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses.

Journal: Hepatology (Baltimore, Md.)

Published: July 25, 2025

External validation of plasma CSF1 as a preoperative prognostic marker in patients with resectable intrahepatic cholangiocarcinoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: February 22, 2025